mRNA-Based Vaccination Drives in Vivo Dendritic Cell Reprogramming and Selective Cytotoxic T Lymphocyte Modulation for Enhanced Antitumor Immunity
ACS Nano · 11.11.2025 · 19 (44) · 38267-38283
DOI: 10.1021/acsnano.5c09365 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 28.10.2025. Verfasst von Chenshuang Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Innovative Immunotherapy, Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmace…. Hauptthemen laut MEDLINE: Dendritic Cells, T-Lymphocytes, Cytotoxic, Cancer Vaccines, RNA, Messenger. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, National Key Research and Development Program of China, National Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Innovative Immunotherapy, Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai 200240, China.
- Department of Chemical and Materials Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States.
- Department of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States.
- Suzhou Biomedical Industry Innovation Center, Suzhou 215000, China.
ORCID-Profile: Xiaoyang Xu, Xue-Qing Zhang
Förderung
- Natural Science Foundation of Shanghai Municipality
- National Key Research and Development Program of China
- National Science Foundation
- ?Open Competition to Select the Best Candidates? Key Technology Program for Nucleic Acid Drugs of NCTIB
- Program of Shanghai Frontiers Science Center of Drug Target Identification and Delivery
- Gustavus and Louise Pfeiffer Research Foundation Award
Zitieren
APA
Zhang, C., Stewart, W., Teng, Y., Hu, B., Xu, X., & Zhang, X. Q. (2025). mRNA-Based Vaccination Drives in Vivo Dendritic Cell Reprogramming and Selective Cytotoxic T Lymphocyte Modulation for Enhanced Antitumor Immunity. ACS Nano, 19(44), 38267-38283. https://doi.org/10.1021/acsnano.5c09365
Vancouver
Zhang C, Stewart W, Teng Y, Hu B, Xu X, Zhang XQ. mRNA-Based Vaccination Drives in Vivo Dendritic Cell Reprogramming and Selective Cytotoxic T Lymphocyte Modulation for Enhanced Antitumor Immunity. ACS Nano. 2025;19(44):38267-38283. doi:10.1021/acsnano.5c09365
BibTeX
@article{Zhang2025,
author = {Zhang, Chenshuang and Stewart, William and Teng, Yilong and Hu, Bin and Xu, Xiaoyang and Zhang, Xue-Qing},
title = {mRNA-Based Vaccination Drives in Vivo Dendritic Cell Reprogramming and Selective Cytotoxic T Lymphocyte Modulation for Enhanced Antitumor Immunity},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {44},
pages = {38267--38283},
doi = {10.1021/acsnano.5c09365}
}
EUVIMED